173 related articles for article (PubMed ID: 9730910)
1. Inhibition of cyclic AMP-dependent kinase by expression of a protein kinase inhibitor/enhanced green fluorescent fusion protein attenuates angiotensin II-induced type 1 AT1 receptor mRNA down-regulation in vascular smooth muscle cells.
Wang X; Murphy TJ
Mol Pharmacol; 1998 Sep; 54(3):514-24. PubMed ID: 9730910
[TBL] [Abstract][Full Text] [Related]
2. The inducible cAMP early repressor ICERIIgamma inhibits CREB and AP-1 transcription but not AT1 receptor gene expression in vascular smooth muscle cells.
Wang X; Murphy TJ
Mol Cell Biochem; 2000 Sep; 212(1-2):111-9. PubMed ID: 11108142
[TBL] [Abstract][Full Text] [Related]
3. The vascular smooth muscle type I angiotensin II receptor mRNA is destabilized by cyclic AMP-elevating agents.
Wang X; Nickenig G; Murphy TJ
Mol Pharmacol; 1997 Nov; 52(5):781-7. PubMed ID: 9351968
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide.
Ichiki T; Usui M; Kato M; Funakoshi Y; Ito K; Egashira K; Takeshita A
Hypertension; 1998 Jan; 31(1 Pt 2):342-8. PubMed ID: 9453326
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression.
Nickenig G; Murphy TJ
Mol Pharmacol; 1994 Oct; 46(4):653-9. PubMed ID: 7969043
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
Wassmann S; Laufs U; Bäumer AT; Müller K; Konkol C; Sauer H; Böhm M; Nickenig G
Mol Pharmacol; 2001 Mar; 59(3):646-54. PubMed ID: 11179461
[TBL] [Abstract][Full Text] [Related]
7. Relationship between internalization and mRNA decay in down-regulation of recombinant type 1 angiotensin II receptor (AT1) expression in smooth muscle cells.
Adams B; Obertone TS; Wang X; Murphy TJ
Mol Pharmacol; 1999 Jun; 55(6):1028-36. PubMed ID: 10347244
[TBL] [Abstract][Full Text] [Related]
8. Negative feedback regulation of reactive oxygen species on AT1 receptor gene expression.
Nickenig G; Strehlow K; Bäumer AT; Baudler S; Wassmann S; Sauer H; Böhm M
Br J Pharmacol; 2000 Oct; 131(4):795-803. PubMed ID: 11030730
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation.
Lassègue B; Alexander RW; Nickenig G; Clark M; Murphy TJ; Griendling KK
Mol Pharmacol; 1995 Oct; 48(4):601-9. PubMed ID: 7476884
[TBL] [Abstract][Full Text] [Related]
10. Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells.
Nickenig G; Murphy TJ
Mol Pharmacol; 1996 Oct; 50(4):743-51. PubMed ID: 8863818
[TBL] [Abstract][Full Text] [Related]
11. Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin.
Kohno M; Yasunari K; Minami M; Kano H; Maeda K; Mandal AK; Inoki K; Haneda M; Yoshikawa J
J Am Soc Nephrol; 1999 Dec; 10(12):2495-502. PubMed ID: 10589687
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of angiotensin receptor mRNA down-regulation in vascular smooth muscle. Post-transcriptional control by protein kinase a but not mitogenic signaling directed by the 5'-untranslated region.
Xu K; Murphy TJ
J Biol Chem; 2000 Mar; 275(11):7604-11. PubMed ID: 10713068
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP-mediated inhibition of angiotensin II-induced protein synthesis is associated with suppression of tyrosine phosphorylation signaling in vascular smooth muscle cells.
Giasson E; Servant MJ; Meloche S
J Biol Chem; 1997 Oct; 272(43):26879-86. PubMed ID: 9341120
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C and protein kinase A regulate the expression of angiotensin II receptor mRNA in smooth muscle cells.
Chen X; Nishimura J; Hasna J; Kobayashi S; Shikasho T; Kanaide H
Eur J Pharmacol; 1994 Apr; 267(2):175-83. PubMed ID: 7519561
[TBL] [Abstract][Full Text] [Related]
15. Regulation of vascular angiotensin II receptors by EGF.
Ullian ME; Raymond JR; Willingham MC; Paul RV
Am J Physiol; 1997 Oct; 273(4):C1241-9. PubMed ID: 9357768
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells.
Cospedal R; Lobo M; Zachary I
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):407-14. PubMed ID: 10455028
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
Arai H; Escobedo JA
Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
[TBL] [Abstract][Full Text] [Related]
18. The cyclosporin A-sensitive nuclear factor of activated T cells (NFAT) proteins are expressed in vascular smooth muscle cells. Differential localization of NFAT isoforms and induction of NFAT-mediated transcription by phospholipase C-coupled cell surface receptors.
Boss V; Abbott KL; Wang XF; Pavlath GK; Murphy TJ
J Biol Chem; 1998 Jul; 273(31):19664-71. PubMed ID: 9677394
[TBL] [Abstract][Full Text] [Related]
19. CV-11974, the active metabolite of TCV-116 (Candesarten), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells.
Sachinidis A; el-Haschimi K; Ko Y; Seul C; Düsing R; Vetter H
Biochem Pharmacol; 1996 Jul; 52(1):123-6. PubMed ID: 8678895
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D1-like receptor stimulation inhibits hypertrophy induced by platelet-derived growth factor in cultured rat renal vascular smooth muscle cells.
Yasunari K; Kohno M; Kano H; Yokokawa K; Minami M; Yoshikawa J
Hypertension; 1997 Jan; 29(1 Pt 2):350-5. PubMed ID: 9039126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
